- Child Car Seat Safety Tip: Skip Puffy Winter Coats
- UK Prime Minister Says British COVID Variant May Be More Deadly
- FDA Approves First Once-a-Month HIV Therapy
- Half of Americans Still Not Wearing Masks When Out in Public: Poll
- For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot
- AHA News: Anxiety Is Linked With Smoking – But How Is Still Hazy
- Biden Warns of 500,000 COVID Deaths by February
- Health Highlights: Jan. 22, 2021
- For Rising Number of People, Obesity Is a Literal Headache
- Even When Cancer Is in Remission, Patients’ Risks of Severe COVID Rise
Generic Aciphex Approved to Treat Chronic Heartburn
FRIDAY, Nov. 8The first generic versions of the anti-GERD drug Aciphex (rabeprazole sodium) have been approved by the U.S. Food and Drug Administration for people aged 12 and older, the agency said Friday.
Gastroesophageal reflux disease (GERD), also known as chronic heartburn, is a very common disorder characterized by backward flow of stomach acid to the esophagus. This process could damage tissue in the esophagus, the tube that connects the throat and stomach.
License to produce generic rabeprazole was granted to Dr. Reddy’s Laboratories, Kremers Urban Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Teva Pharmaceuticals and Torrent Pharmaceuticals, the FDA said.
The drug is among a class called proton-pump inhibitors, which are designed to reduce the amount of stomach acid produced. Generic drugs, the FDA stressed, are equivalent to the brand-name versions in strength and quality.
More information
To learn more about GERD, visit Medline Plus.
Source: HealthDay
